StockData
Azitra, Inc. logo

Azitra, Inc. (AZTR) stock

AZTRNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 1/30
$0.07+0.00 (0.00%)

Close on Oct 19, 2026Market cap $32.20MP/E –Yield –

Azitra free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Azitra's free cash flow for the twelve months ending Jun 30, 2026 was -$11.17M. For fiscal 2025 it was -$11.25M.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$11.25M–
FY2024Dec 31, 2024-$10.19M–
FY2023Dec 31, 2023-$7.39M–
FY2022Dec 31, 2022-$8.38M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$3.33M–
Q1 FY2026Mar 31, 2026-$2.49M–
Q4 FY2025Dec 31, 2025-$2.90M–
Q3 FY2025Sep 30, 2025-$2.45M–
Q2 FY2025Jun 30, 2025-$2.83M–
Q1 FY2025Mar 31, 2025-$3.07M–
Q4 FY2024Dec 31, 2024-$2.59M–
Q3 FY2024Sep 30, 2024-$2.48M–
Q2 FY2024Jun 30, 2024-$2.10M–
Q1 FY2024Mar 31, 2024-$3.02M–
Q4 FY2023Dec 31, 2023-$2.54M–
Q3 FY2023Sep 30, 2023-$1.80M–
Q2 FY2023Jun 30, 2023-$1.73M–
Q1 FY2023Mar 31, 2023-$1.32M–
Q4 FY2022Dec 31, 2022-$2.18M–
Q3 FY2022Sep 30, 2022-$2.08M–

More Azitra figures

See a number that looks wrong?